Neurodevelopmental disabilities are disorders of the brain's development that result in impaired cognitive functions, delay motor skills or language abilities, and can present a range of physical and behavioral symptoms. Neurodevelopmental disabilities are lifelong conditions which can vary in severity, but in all cases, require a multi-disciplinary team approach to treatment. These conditions can be the result of genetic or environmental factors, as well as trauma, infection, inflammation, or exposure to certain environmental toxicants. Common forms of neurodevelopmental disabilities include autism spectrum disorder, attention deficit hyperactivity disorder (ADHD), Cerebral Palsy, Down Syndrome, Tourette Syndrome, and Intellectual Disabilities. Early intervention is key in helping individuals with each of these conditions reach their potential. Such interventions can include occupational and physical therapy, speech and language therapy, psychotherapy, and Applied Behavioral Analysis. Each of these therapies is focused on developing the individual’s skills and addressing their challenges in activities such as writing, reading, socializing, or concentration. To create an effective treatment plan that works with the individual’s strengths and abilities, as well as those of their family, it is important to have a positive and collaborative relationship between all involved professionals, family, and of course the individual themselves. Parents and families of individuals with neurodevelopmental disabilities should be included as active participants in the planning process, regularly updated on progress, allowed to have input on treatment objectives, and supported when it comes to making decisions. To provide the best support for an individual with neurodevelopmental disabilities, it is helpful to have an understanding of the individual’s unique needs and abilities. Such understanding comes from an in-depth appraisal of the individual’s capabilities, assessing their aptitudes, capabilities, and challenges. Through this type of individualized assessment, an appropriate intervention plan can be created to help the individual reach their fullest potential and maintain a positive quality of life
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States